<VariationArchive RecordType="classified" VariationID="17979" VariationName="PI NULL(PROCIDA)" VariationType="Deletion" Accession="VCV000017979" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-04-25" DateCreated="2016-05-06" MostRecentSubmission="2016-07-19">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="33018" VariationID="17979">
      <GeneList>
        <Gene Symbol="SERPINA1" FullName="serpin family A member 1" GeneID="5265" HGNC_ID="HGNC:8941" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>14q32.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="94376747" stop="94390635" display_start="94376747" display_stop="94390635" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NT_187601.1" start="1493319" stop="1507207" display_start="1493319" display_stop="1507207" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="94843083" stop="94857028" display_start="94843083" display_stop="94857028" Strand="-" />
          </Location>
          <OMIM>107400</OMIM>
        </Gene>
      </GeneList>
      <Name>PI NULL(PROCIDA)</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q32.1</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>PI NULL(ISOLA DI PROCIDA)</Name>
        <Name>PI Q0(PROCIDA)</Name>
        <Name>QOisola di procida</Name>
        <Name>17-kb del</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008290.1" sequenceAccession="NG_008290" sequenceVersion="1" change="g.8801_20594del">
            <Expression>NG_008290.1:g.8801_20594del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_575" sequenceAccession="LRG_575">
            <Expression>LRG_575:g.8801_20594del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="107400.0023" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence defining the breakpoints of the deletion (Takahashi and Crystal, 1990, PubMed 1975477, Fig 5) to establish the location of this deletion.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="PI NULL(PROCIDA) AND PI NULL(PROCIDA)" Accession="RCV000019584" Version="4">
        <ClassifiedConditionList TraitSetID="6012">
          <ClassifiedCondition>PI NULL(PROCIDA)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-07-15" SubmissionCount="1">other</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="PI NULL(PROCIDA) AND Alpha-1-antitrypsin deficiency" Accession="RCV000203601" Version="2">
        <ClassifiedConditionList TraitSetID="6720">
          <ClassifiedCondition DB="MedGen" ID="C0221757">Alpha-1-antitrypsin deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2014-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-07-15" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-05-06" MostRecentSubmission="2016-07-19">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic; other</Description>
        <Citation Type="general">
          <ID Source="PubMed">14985567</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1975477</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3262617</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301692</ID>
          <ID Source="BookShelf">NBK1519</ID>
        </Citation>
        <DescriptionHistory Dated="2022-03-18">
          <Description>Pathogenic, other</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-03-19">
          <Description>Pathogenic, other</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-03-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6012" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="13013" Type="NamedProteinVariant">
              <Name>
                <ElementValue Type="Preferred">PI NULL(PROCIDA)</ElementValue>
                <XRef Type="Allelic variant" ID="107400.0023" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PI Q0(PROCIDA)</ElementValue>
                <XRef Type="Allelic variant" ID="107400.0023" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PI NULL(ISOLA DI PROCIDA)</ElementValue>
                <XRef Type="Allelic variant" ID="107400.0023" DB="OMIM" />
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="6720" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15742" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Alpha-1-antitrypsin deficiency</ElementValue>
                <XRef ID="Alpha+1-Antitrypsin+Deficiency/325" DB="Genetic Alliance" />
                <XRef ID="30188007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha1-Antitrypsin Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AAT deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">A1AT deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">A1ATD</ElementValue>
                <XRef Type="MIM" ID="613490" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AATD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5784" />
                <XRef ID="5784" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Alpha-1 antitrypsin deficiency (AATD) can present with hepatic dysfunction in individuals from infancy to adulthood and with chronic obstructive lung disease (emphysema and/or bronchiectasis), characteristically in individuals older than age 30 years. Individuals with AATD are also at increased risk for panniculitis (migratory, inflammatory, tender skin nodules which may ulcerate on legs and lower abdomen) and C-ANCA-positive vasculitis (granulomatosis with polyangiitis). Phenotypic expression varies within and between families. In adults, smoking is the major factor in accelerating the development of COPD; nonsmokers may have a normal life span, but can also develop lung and/or liver disease. Although reported, emphysema in children with AATD is extremely rare. AATD-associated liver disease, which is present in only a small portion of affected children, manifests as neonatal cholestasis. The incidence of liver disease increases with age. Liver disease in adults (manifesting as cirrhosis and fibrosis) may occur in the absence of a history of neonatal or childhood liver disease. The risk for hepatocellular carcinoma (HCC) is increased in individuals with AATD.</Attribute>
                <XRef ID="NBK1519" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301692</ID>
                <ID Source="BookShelf">NBK1519</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ATS/ERS, 2003">
                <ID Source="PubMed">15685488</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="pmc">3083625</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2010">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_Alpha1Antitrypsin-enPro194.pdf</URL>
                <CitationText>Orphanet, Alpha-1 antitrypsin deficiency, 2010</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <XRef ID="60" DB="Orphanet" />
              <XRef ID="C0221757" DB="MedGen" />
              <XRef ID="MONDO:0013282" DB="MONDO" />
              <XRef Type="MIM" ID="613490" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39882" SubmissionDate="2016-07-15" DateLastUpdated="2016-07-19" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="107400.0023_PI NULL(PROCIDA)" title="SERPINA1, 17-KB DEL_PI NULL(PROCIDA)" />
        <ClinVarAccession Accession="SCV000039882" DateUpdated="2016-07-19" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000039883" DateChanged="2016-05-06" Version="1" />
          <Replaced Accession="SCV000039884" DateChanged="2016-05-06" Version="1" />
        </ReplacedList>
        <Classification DateLastEvaluated="2016-07-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>other</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Of the 5 previously known representatives of the 'null' group of AAT-deficient alleles (i.e., genes incapable of producing AAT protein detectable in serum) evaluated at the gene level, all had stop codons in coding exons. Cloning and mapping of the Null(Isola di Procida) gene demonstrated deletion of a 17-kb fragment that included exons 2-5 of the AAT structural gene (Takahashi and Crystal, 1990). Sequence analysis showed a 7-bp repeat sequence both 5-prime to the deletion and at the 3-prime end of the deletion, suggesting that the mechanism of the deletion may have been a slipped mispairing. This mutation, which at first was called Null(Procida), was found in heterozygous state with the M(Procida) allele (107400.0016) reported by Takahashi et al. (1988). To avoid confusion with M(Procida), Null(Procida) was renamed Null(Isola di Procida). This mutation is associated with high risk of emphysema.</Attribute>
              <Citation>
                <ID Source="PubMed">1975477</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">3262617</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SERPINA1" />
          </GeneList>
          <Name>SERPINA1, 17-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">17-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="107400.0023" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PI NULL(PROCIDA)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="479071" SubmissionDate="2016-01-22" DateLastUpdated="2016-05-06" DateCreated="2015-11-14">
        <ClinVarSubmissionID localKey="17-kb_del|OMIM:613490" />
        <ClinVarAccession Accession="SCV000256627" DateUpdated="2016-05-06" DateCreated="2015-11-14" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000258943" DateChanged="2016-05-06" Version="1" />
        </ReplacedList>
        <Classification DateLastEvaluated="2014-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14985567</ID>
          </Citation>
          <Citation>
            <URL>http://www.ncbi.nlm.nih.gov/books/NBK1519/</URL>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SERPINA1" />
          </GeneList>
          <Name>QOisola di procida</Name>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">17-kb del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613490" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment Type="public">Disease association: lung</Comment>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="39882" TraitType="Disease" MappingType="Name" MappingValue="PI NULL(PROCIDA)" MappingRef="Preferred">
        <MedGen CUI="C4015817" Name="PI NULL(PROCIDA)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="479071" TraitType="Disease" MappingType="XRef" MappingValue="613490" MappingRef="OMIM">
        <MedGen CUI="C0221757" Name="Alpha-1-antitrypsin deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

